Innovative Point of Care Products and Services
Simplicity, Accuracy, Reliability
Biomarkers or diagnostic parameters that ensure immediate and effective treatment or prevention
Innovative Medical Services! Diagnosis - Treatment Evaluation - Prevention
DyonMed innovates and manufactures the first in Greece “Point of Care” Testing products, offering targeted diagnostics solutions – Private offices – Ambulance – Clinic – Outpatient – Pharmacy – Home
With the application of specialized products the healthcare professional can manage diseases of the gastrointestinal system. Management of Helicobacter Pylori Infection at the level of diagnosis and evaluation of the eradication therapy can maximize the therapeutic effect. Diagnostic semi-quantitative evaluation of the biomarker calprotectin is a key innovation of DyonMed for the management of IBD (Idiopathic Inflammatory Bowel Disease).
A series of specialized diagnostic products enable the semi-quantitative control of the CRP biomarker to determine the importance and severity of an infection within 5 minutes. Extremely high-reliability diagnostic products of type A antigen for seasonal influenza, which includes all types, enable the therapist to cure targeted and participate actively in reducing the transmission of seasonal influenza. DyonMed SA, the first Greek company POINT OF CARE TESTING, is being innovative once again and is launching the DyonCOVID19® in market.
Our specialized Point of Care products are explicitly designed so that they can be used individually for each patient but also as an important diagnostic tool in hospital visits, or even in an ambulance and in a hospital emergency. One drop of capillary blood and 5 minutes are enough to identify biomarkers such as troponin, myoglobin, CK-MB and to effectively and immediately manage the patient’s health care wherever he or she is.
DyonCovid19® is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It is to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.
DyonHpsA® (H. pylori stool Ag) is the first in the world to test helicobacter pylori antigen with specificity, sensitivity, positive and negative prognostic value that reaches 99% in histological comparison studies.
Its reliability is not affected by the concomitant use of antecedent treatment
Νo more than 2 drops of blood and 15 minutes are enough to have Negative coincidence rate > 97.5% vs PCR.
SARS-CoV-2 IgM/IgG Antibody Rapid Test Device.
SARS-CoV 2 (COVID-19), it is a novel coronavirus with new strain that has not been previously identified in humans, belongs to Coronaviruses (CoV) such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
• Easy to use • High accuracy • Fast result
THE FIRST GREEK COMPANY SPECIALIZED IN POINT OF CARE PRODUCTS AND SERVICES
The DyonCalpro® (Calprotectin) is a rapid immunochromatographic test for the qualitative detection Calprotectin in stool samples. The use of Calprotectin extends to cases of children with idiopathic inflammatory bowel disease and has proven its reliability and of course the fact that it is a non-invasive monitoring method of pediatric patients.
DyonCOVID19® is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It is to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2 .
EN ISO 9001:2015
EN ISO 13485:2016